CD44 Expression in Colorectal Cancer

[1]  M. Zeitz,et al.  Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6 , 1998, American Journal of Gastroenterology.

[2]  T. Urano,et al.  Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Griffioen,et al.  Signaling through CD44 Is Mediated by Tyrosine Kinases , 1996, The Journal of Biological Chemistry.

[4]  P. Schlag,et al.  Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins , 1995, The Lancet.

[5]  J. Oosting,et al.  Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins , 1994, The Lancet.

[6]  Jing Ma,et al.  Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. , 1994, Cancer research.

[7]  P. Herrlich,et al.  A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. , 1993, Cancer research.

[8]  J. Bell,et al.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Martin Hofmann,et al.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.

[10]  J. Sleeman,et al.  The CD44 proteins in embryonic development and in cancer. , 1996, Current topics in microbiology and immunology.